VCG. Tesla’s Shanghai Gigafactory stood out as a major growth engine in the American EV giant’s second-quarter earnings, released o ……
Singapore Businesses Brace for Impacts of Upcoming RTS Link
Businesses in northern Singapore are preparing for the imminent opening of the RTS Link, which is set to reshape the…
Singapore Businesses Brace for Impacts of Upcoming RTS Link comes from ChinaRetailNews.com. ChinaRetailNews.com: ChinaRetailNews.com……
Nike Initiates Bold Strategy to Revive Sales in China by Restricting Online Sellers
Nike is implementing a bold strategy in China aimed at reviving its sales and regaining control over pricing dynamics. Following…
Nike Initiates Bold Strategy to Revive Sales in China by Restricting Online Sellers comes from ChinaRetailNews.com. Chin……
Chinese Investment Bill Threatens Mercedes and U.S. Automakers
In a pivotal legislative move, the Senate Commerce Committee is on the verge of implementing restrictive measures to block Chinese……
US Startups Urge Government to Reconsider Ban on Chinese AI Models
A growing conflict revolving around Chinese artificial intelligence has extended its reach to Silicon Valley. About 200 startups have jointly……
Chinese Economy Awash with Thriving Private Funds Influx
China’s private securities investment funds have surged to over 8 trillion yuan (US$1.2 trillion) marking a significant milestone in the……
China’s Involvement Facing Scrutiny: FCC Ruling Prohibits Sale of Devices from High-Risk Chinese Firms
The Federal Communications Commission (FCC) issued a groundbreaking ruling to prevent the sale of electronic devices incorporating parts from Chinese……
AI shortens drug discovery to around 1 year in China, Insilico CEO says
By Laurie Chen SHANGHAI, July 23 (Reuters) – Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, ……
AI shortens drug discovery to around 1 year in China, Insilico CEO says
By Laurie Chen SHANGHAI, July 23 (Reuters) – Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, ……
AI shortens drug discovery to around 1 year in China, Insilico CEO says
By Laurie Chen SHANGHAI, July 23 (Reuters) – Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, ……
-
-
Recent Updates
- KraneShares Announces Inclusion of CXMT in China Semiconductor ETF
- Escalating U.S. Action Targets Chinese Data Center Tech Amid Heightened Security Concerns
- Critical Concerns Raised Over New Security Regulations on Robotics in Response to Ongoing Advances
- Shein Targets $40 Billion Valuation in Hong Kong IPO
- AsymBio Receives $184 Million Investment to Fuel Long-Term Growth
- Tesla’s China footprint complicates path to possible SpaceX merger
- China’s Methanol Revolution: A Success Story in Clean Transport Innovation
- 2026 China-U.S. Young Maker Competition Finals Conclude Successfully in Zhangjiang, Shanghai
- De Beers Group debuts Desert diamonds in Shanghai
- Tesla reports July deliveries of 93,579 units in China, up sharply from last year
Blogroll